Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] North America Generics North America Generics [Member] North America Generics [Member] Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Other long-term obligations Other Noncurrent Liabilities [Member] Inventory Valuation Reserves Inventory Valuation Reserves Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Stock option award expiration period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Deferred income tax liability Deferred Income Tax Liabilities, Net Yupelri ® Yupelri ® [Member] Yupelri ® Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Variable Interest Entity, Maximum Milestone Payments Variable Interest Entity, Maximum Milestone Payments Variable Interest Entity, Maximum Milestone Payments Insider Trading Policies and Procedures [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Ownership [Axis] Ownership [Axis] Andrew Cuneo [Member] Andrew Cuneo Reporting Unit [Domain] Reporting Unit [Domain] Current liabilities: Liabilities, Current [Abstract] Payments to Acquire in Process Research and Development Payments to Acquire in Process Research and Development Goodwill, Impaired, Accumulated Impairment Loss Goodwill, Impaired, Accumulated Impairment Loss Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Subsequent Event Type [Domain] Subsequent Event Type [Domain] Program Name [Axis] Program Name [Axis] Program Name Proceeds from Divestiture of Businesses Proceeds from Divestiture of Businesses Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Diluted (in USD per share) Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted Treasury Stock, Value Treasury Stock, Value Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Receivable [Domain] Receivable [Domain] Land and improvements Land and Land Improvements [Member] Line of Credit [Member] Line of Credit [Member] Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax North America Segment North America Segment [Member] North America Segment Litigation Case [Axis] Litigation Case [Axis] Trading Symbol Trading Symbol Restructuring Plan [Domain] Restructuring Plan [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Available-for-sale fixed income investments Debt Securities [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Machinery and equipment Machinery and Equipment [Member] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Viatris Inc. shareholders’ equity Equity, Attributable to Parent [Abstract] 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Service cost Defined Benefit Plan, Service Cost Executive Category: Executive Category [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Level 1 Fair Value, Inputs, Level 1 [Member] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] 2024 Long-Term Debt, Maturity, Year Two Entity Small Business Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Upjohn Distributor Markets Upjohn Distributor Markets [Member] Upjohn Distributor Markets Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Amounts due for supplier finance program Supplier Finance Program, Obligation Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Restricted cash Restricted Cash and Cash Equivalents, Current Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted stock awards Restricted Stock Units (RSUs) [Member] Nonvested Restricted Stock and Restricted Stock Unit Awards Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Taxes related to the net share settlement of equity awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Business Combination [Abstract] Business Combination [Abstract] Equity Method Investments Equity Method Investments [Table Text Block] In Process Research And Development, Fair value Measurement Input, Discount Rate In Process Research And Development, Fair value Measurement Input, Discount Rate In Process Research And Development, Fair value Measurement Input, Discount Rate Period [Domain] Period [Domain] [Domain] for Period [Axis] Term Loan Term Loan [Member] Term Loan Income taxes payable Accrued Income Taxes, Current Total revenues Revenues Revenues Other Liabilities, Other than Long-Term Debt, Noncurrent Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Accounts payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Short-term Debt [Line Items] Short-Term Debt [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Beginning Balance Ending Balance Restructuring Reserve Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Number of restricted stock awards, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Cash, cash equivalents, and restricted cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Document Quarterly Report Document Quarterly Report Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Operating lease liability Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Number of equity method investments Number of equity method investments Number of equity method investments Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term Disposal Group, Including Discontinued Operation, Transition Services Agreement, Revised Term Other expense Other Expense [Member] Other Expense [Member] 2026 Senior Notes (3.950% coupon) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Counterparty Name [Domain] Counterparty Name [Domain] Notional amount of derivative Derivative Asset, Notional Amount Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Issuance of restricted stock and stock options exercised, net Restricted Stock, Value, Shares Issued Net of Tax Withholdings Fair value of long-term debt Debt Instrument, Fair Value Disclosure Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Assets held for sale Disposal Group, Including Discontinued Operation, Intangible Assets Exchange traded funds Exchange Traded Funds [Member] Business Combination, Consideration Transferred Business Combination, Consideration Transferred Gross profit Gross loss Gross Profit Security Exchange Name Security Exchange Name 2019 Senior Notes (2.550% coupon) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen Biocon Biologics Biocon Biologics [Member] Biocon Biologics Selling, general and administrative Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated other comprehensive loss, net of tax, beginning of period Accumulated other comprehensive loss, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Collaboration and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] Stock awards Employee Stock Option [Member] Senior Notes 2022 Senior Notes 2022 [Member] Senior Notes 2022 Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Recognized net actuarial (gains)/losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Maximum Maximum [Member] Restructuring - employee related Restructuring and Related Costs [Table Text Block] Total unrecognized compensation expense, net of estimated forfeitures Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Acquisitions Goodwill, Acquired During Period Tabular List, Table Tabular List [Table Text Block] Common stock repurchase Treasury Stock, Value, Acquired, Cost Method Thereafter Long-Term Debt, Maturity, after Year Five Share-Based Incentive Plan Share-Based Payment Arrangement [Text Block] Basis of Accounting Policy Basis of Accounting, Policy [Policy Text Block] Other non-cash items Other Noncash Income (Expense) Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Business Acquisition [Axis] Business Acquisition [Axis] Damages to be paid Loss Contingency, Damages Paid, Value Famy Life Sciences Acquisition Famy Life Sciences Acquisition [Member] Famy Life Sciences Acquisition Derivative [Table] Derivative [Table] Inventories Inventories [Member] Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances Accrued Sales Allowances Raw materials Inventory, Raw Materials, Net of Reserves 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Other noncurrent liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Acquisitions and Other Transactions Business Combination Disclosure [Text Block] In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Subsidiary, Ownership Percentage, Noncontrolling Owner Subsidiary, Ownership Percentage, Noncontrolling Owner Operating Segment Operating Segments [Member] Weighted average grant-date fair value per share, nonvested beginning of period Weighted average grant-date fair value per share, nonvested end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Cash dividends paid Payments to Noncontrolling Interests Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Oyster Point Pharma Acquisition Oyster Point Pharma Acquisition [Member] Oyster Point Pharma Acquisition Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Payment Arrangement [Abstract] Line of Credit Facility, Covenant Terms Line of Credit Facility, Covenant Terms Entity Tax Identification Number Entity Tax Identification Number Multi District Litigation [Member] Multi District Litigation [Member] Multi District Litigation [Member] Purchase of marketable securities Payments to Acquire Marketable Securities Range [Axis] Statistical Measurement [Axis] Senior Notes 2021 Senior Notes 2021 [Member] Senior Notes 2021 Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Corporate costs Corporate costs Corporate costs Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement Name Outstanding Recovery, Individual Name Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrecognized gains (losses) on derivatives, net of tax, end of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Rest of World Segment [Member] Rest of World Segment [Member] Rest of World Segment Other Other Debt Obligations [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2024 Euro Senior Notes, 1.023% 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Equity Securities, FV-NI Equity Securities, FV-NI Counterparty Name [Axis] Counterparty Name [Axis] Trailing Four Quarters [Member] Trailing Four Quarters [Member] Trailing Four Quarters 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Dividends Dividends Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Generics Generics [Member] Generics Pension and Other Postretirement Benefits Disclosure Retirement Benefits [Text Block] Basic (in shares) Weighted Average Basic Shares Outstanding, Pro Forma Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Par or Stated Value Per Share Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Interest rate swaps Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Estimated employer contributions in current year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Current assets (excluding inventories and net of cash acquired) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Measurement Input Type [Domain] Measurement Input Type [Domain] Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Capital Shares Reserved for Future Issuance Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Number of states Number of states Number of states Other Comprehensive Income (Loss), before Tax Other Comprehensive Income (Loss), before Tax Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Segment Reporting Policy Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Other Comprehensive Income (Loss), before Tax [Abstract] Other Comprehensive Income (Loss), before Tax [Abstract] Loss Contingency, Damages Sought Loss Contingency, Damages Sought Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Gains and Losses on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Asset Impairment Charges Asset Impairment Charges Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Total intangible asset amortization expense (including disposal & impairment charges) Amortization Restructuring Type [Axis] Restructuring Type [Axis] Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Earnings per Share Policy Earnings Per Share, Policy [Policy Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] New Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Other Other Long Term Debt [Member] Other long term debt. Variable Interest Entity, Financial or Other Support, Amount Variable Interest Entity, Financial or Other Support, Amount Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Weighted average grant-date fair value per share, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Asset-backed Securities Asset-Backed Securities [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Private Equity Securities Private Equity Securities [Member] Private Equity Securities Depreciation and amortization Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Commercial Paper [Member] Commercial Paper [Member] Consolidation Items [Axis] Consolidation Items [Axis] Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Revenue Goodwill, Impairment Loss Goodwill, Impairment Loss Lyrica ® Lyrica ® [Member] Lyrica ® Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Number Of Challenged Statements Number Of Challenged Statements Number Of Challenged Statements Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Number Of Entities, National Health Service England, Wales, And Northern Ireland Number Of Entities, National Health Service England, Wales, And Northern Ireland Number Of Entities, National Health Service England, Wales, And Northern Ireland Number Of Challenged Statements Dismissed Number Of Challenged Statements Dismissed Number Of Challenged Statements Dismissed Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year Loss Contingency, Asset Impairment, Disposal Transactions Not Completed In Current Fiscal Year Zoloft ® Zoloft ® [Member] Zoloft ® 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Equivalent percentage of redeemed amount Equivalent Price Percentage Of Principal Amount Redeemable Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date. Mylan N.V. Parent Company [Member] Acquired intangible assets Identified intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Goodwill Impairment, Measurement Input Increase Goodwill Impairment, Measurement Input Increase Goodwill Impairment, Measurement Input Increase Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title Common Stock Marketable securities Common Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Individual: Individual [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reduction due to lapse in statues Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Income Statement Location [Domain] Income Statement Location [Domain] Effect on Future Cash Flows, Amount Effect on Future Cash Flows, Amount Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Total equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Trade receivables, net Receivables, Net, Current Dividends paid (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Other Comprehensive Income (Loss), Net of Tax, Total Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Fair value loss Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Liabilities Liabilities [Abstract] Other Current Assets Other Current Assets [Member] U.S. Treasuries US Treasury Securities [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred income tax benefit Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Retained Earnings Retained Earnings [Member] Retained Earnings [Member] 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Current portion of long-term debt and other long-term obligations Long-Term Debt, Current Maturities Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Trade accounts payable Accounts Payable, Trade Basic (in USD per share) Basic earnings per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory 2019 Senior Notes (2.500% coupon) SeniorNotesTwoThousandNineteen2.50Precent [Member] 2019 Senior Notes (2.500%) Contingent consideration Contingent Consideration [Member] Contingent Consideration. Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Variable Consideration Variable Consideration [Member] Variable Consideration [Member] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Interest Expense [Member] Interest Expense [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Period [Axis] Period [Axis] Period [Axis] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative Instruments Risk [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Total Long-Term Debt, Gross Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Liability Class [Axis] Liability Class [Axis] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Compensation Amount Outstanding Recovery Compensation Amount Complex GX and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars Emerging Markets Segment Emerging Markets Segment [Member] Emerging Markets Segment Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Interest rate swap derivative assets Derivative Asset Weighted average grant-date fair value per share, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Deferred income tax benefit Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of restricted stock awards, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period 2023 Long-Term Debt, Maturity, Year One Restructuring Reserve, Current Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Assets Other Assets Equity method investments summarized financial data basis Equity Method Investments Summarized Financial Data Basis Equity Method Investments Summarized Financial Data Basis Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Equity Securities, FV-NI, Unrealized Gain (Loss) Equity Securities, FV-NI, Unrealized Gain (Loss) Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Cash payment Payments for Restructuring Document Period End Date Document Period End Date 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Adoption Date Trading Arrangement Adoption Date Sales [Member] Sales [Member] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Treasury Stock Treasury Stock, Common [Member] Opiod Civil Litigation Opiod Civil Litigation [Member] Opiod Civil Litigation Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Loss Contingency Accrual Loss Contingency Accrual Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Income tax (benefit) provision Income tax expense Income Tax Expense (Benefit) Designated as Hedging Instrument Designated as Hedging Instrument [Member] Basic (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Equity [Abstract] Equity [Abstract] Dymista ® Dymista ® [Member] Dymista ® Other receivables Other Receivables, Net, Current Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Money market funds Money Market Funds [Member] Expected reduction to tax expense by CARES Act Effective Income Tax Rate Reconciliation, CARES Act, Amount Effective Income Tax Rate Reconciliation, CARES Act, Amount Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash paid for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value Treasury Stock, Shares, Acquired Treasury Stock, Shares, Acquired Measurement Input, Control Premium Measurement Input, Control Premium [Member] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] 2018 Senior Notes (2.600% coupon) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Measurement Input, EBITDA Multiple Measurement Input, EBITDA Multiple [Member] 2020 Floating Rate Euro Notes 2020 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Additional Paid-In Capital Additional Paid-in Capital [Member] Ocular AS Ocular AS [Member] Ocular AS Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Gain from equity method investments Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Other long-term obligations Other Liabilities, Noncurrent Long-Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Cash Flow Hedging Cash Flow Hedging [Member] Total operating expenses Operating Expenses Segment Information Segment Reporting Disclosure [Text Block] Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Equity Component [Domain] Equity Component [Domain] Work in process Inventory, Work in Process, Net of Reserves Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Entity Current Reporting Status Entity Current Reporting Status Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Earnings from operations Operating Income (Loss) Contingent consideration payments Payments of Merger Related Costs, Financing Activities Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate Consolidated Entities [Domain] Consolidated Entities [Domain] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Segments [Axis] Segments [Axis] Accretion expense Accretion Expense Scenario, Unspecified [Domain] Scenario [Domain] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Agency mortgage-backed securities Collateralized Mortgage-Backed Securities [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Xalabrands Xalabrands [Member] Xalabrands Consolidated Entities [Axis] Consolidated Entities [Axis] Pay vs Performance Disclosure [Line Items] Range [Domain] Statistical Measurement [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Number of restricted stock awards, nonvested beginning of period Number of restricted stock awards, nonvested end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Debt Debt Disclosure [Text Block] Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Equity securities Debt Securities, Trading, and Equity Securities, FV-NI Other Current Liabilities [Member] Other current liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Number of Countries in which Entity Operates Number of Countries in which Entity Operates Revolving Credit Facility Revolving Credit Facility [Member] Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, end of period Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Write down of intangible assets Impairment of Intangible Assets, Finite-Lived Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Average remaining contractual term for stock awards exercisable, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Discontinued Operations and Disposal Groups [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Pension and other postretirement benefits Other Pension, Postretirement and Supplemental Plans [Member] Investment, Name [Axis] Investment, Name [Axis] Proceeds from sale of terminated interest rate swaps Proceeds from Sale of Securities, Operating Activities Intangible asset disposal & impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Issuance of common stock Proceeds from Issuance of Common Stock 2021 Senior Notes (3.150% coupon) SeniorNotesTwoThousandTwentyOne3.15Precent [Member] 2021 Senior Notes 3.15% Schedule of Goodwill [Table] Schedule of Goodwill [Table] Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Viagra ® Viagra ® [Member] Viagra ® Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Business Acquisition [Line Items] Business Acquisition [Line Items] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Fair value of financial instruments Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Goodwill [Roll Forward] Goodwill [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Business Acquisition, Share Price Business Acquisition, Share Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock, shares Treasury Stock, Common, Shares Treasury Stock, Common, Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Estimated litigation liability Estimated Litigation Liability Buildings and improvements Building and Building Improvements [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Net Income (Loss) Net Income (Loss) Income tax provision (benefit) Other Comprehensive Income (Loss), Tax Total current liabilities Liabilities, Current Derivative Contract Type [Domain] Derivative Contract [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Corporate Bond Securities [Member] Corporate Bond Securities [Member] Accrued interest Interest Payable, Current Balance (in shares) Balance (in shares) Shares, Issued LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Net unrecognized gain on derivatives in cash flow hedging relationships Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Cost of sales Cost of Goods and Services Sold Income Tax Contingency [Table] Income Tax Contingency [Table] Stock option award vesting period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Foreign currency forward contracts Foreign currency borrowings Foreign Exchange Contract [Member] Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Name Measure Name Patents and technologies Patents [Member] Name Forgone Recovery, Individual Name Goodwill Goodwill Goodwill, net, beginning balance Goodwill Underlying Securities Award Underlying Securities Amount Utilization Restructuring and Related Cost, Incurred Cost Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Scenario, Forecast Forecast [Member] Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Prepaid Expense and Other Assets [Abstract] Prepaid Expense and Other Assets [Abstract] Accounts payable Increase (Decrease) in Accounts Payable, Trade Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Other Comprehensive Income, Gain (Loss), Defined Benefit Plan, Divestiture Of Plan Foreign exchange forward contracts Foreign Exchange Forward [Member] Number of cases Number of cases Number of cases JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Inventories Increase (Decrease) in Inventories Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Total Mylan N.V. equity, before treasury stock Stockholders Equity Parent Before Treasury Stock Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock. Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Plan Name [Domain] Plan Name [Domain] Interest expense Interest Expense Ordinary shares reserved for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Average remaining contractual term for stock awards outstanding, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Other Additional Capital Adjustments to Additional Paid in Capital, Other 2023 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Business Combination, Contingent Consideration, Liability, Measurement Input Business Combination, Contingent Consideration, Liability, Measurement Input Deferred consideration due from Biocon Biologics Disposal Group, Including Discontinued Operation, Deferred Consideration Due Disposal Group, Including Discontinued Operation, Deferred Consideration Due Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] 2048 Senior Notes (5.200%) SeniorNotesTwoThousandFortyEight [Member] SeniorNotesTwoThousandFortyEight [Member] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] 2025 Long-Term Debt, Maturity, Year Three Consolidated Entity Consolidated Entity, Excluding VIE [Member] Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] 2.125% Euro Senior Notes due 2025 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Intangible asset amortization expense Amortization of Intangible Assets Amortization of Intangible Assets Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization Business Acquisition, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization Entity Shell Company Entity Shell Company Business Acquisition, Contingent Consideration Per Share Business Acquisition, Contingent Consideration Per Share Business Acquisition, Contingent Consideration Per Share Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Restatement Determination Date Restatement Determination Date Other revenues Revenue Not from Contract with Customer Income taxes Increase (Decrease) in Income Taxes Payable Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Net unrecognized gain (loss) on derivatives Net unrecognized losses on derivatives in net investment hedging relationships, net of tax Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Note Securitization Facility Note Securitization Facility [Member] Note Securitization Facility [Member] Citalopram Litigation Citalopram Litigation [Member] Citalopram Litigation SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] Number of restricted stock awards, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Total assets at recurring fair value measurement Assets, Fair Value Disclosure Long-term debt Long-Term Debt 2026 Long-Term Debt, Maturity, Year Four Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Influvac ® Influvac ® [Member] Influvac ® Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Net unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax North America Brands North America Brands [Member] North America Brands [Member] Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other items, net Proceeds from (Payments for) Other Financing Activities Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive Income (Loss), Net of Tax, Attributable to Parent Diluted (in usd per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Entity Address, Address Line One Entity Address, Address Line One Receivable Type [Axis] Receivable Type [Axis] Divestiture of Business, Deferred Cash Consideration. Divestiture of Business, Deferred Cash Consideration. Divestiture of Business, Deferred Cash Consideration. Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Other payables Accounts Payable, Other Subsequent Event Subsequent Event [Member] Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other current liabilities Other Liabilities, Current Other Liabilities, Current Income Statement [Abstract] Income Statement [Abstract] Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) Other current assets Other Assets, Current Financial Instruments and Risk Management Financial Instruments Disclosure [Text Block] Inventories Inventories Inventory, Net Financial Instrument [Axis] Financial Instrument [Axis] Disposal Groups, Including Discontinued Operations, Disclosure Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total Shareholder Return Amount Total Shareholder Return Amount Payments for Repurchase of Common Stock Purchase of common stock Payments for Repurchase of Common Stock Entity Ordinary Shares, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Segments [Domain] Segments [Domain] Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-Term Revenue Growth Rate [Member] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) 2018 Senior Notes (3.000% coupon) Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent Noncash or Part Noncash Divestiture, Amount of Consideration Received Noncash or Part Noncash Divestiture, Amount of Consideration Received Diluted (in shares) Pro Forma Weighted Average Shares Outstanding, Diluted Current assets: Assets, Current [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Goodwill, Transfers Goodwill, Transfers Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] 2046 Senior Notes (5.250% coupon) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Asset Class [Domain] Asset Class [Domain] Fair value of financial instruments Derivative Asset, Subject to Master Netting Arrangement, before Offset Inventories Schedule of Inventory, Current [Table Text Block] Net earnings (loss) Net earnings attributable to Viatris Inc. common shareholders Net earnings (loss) Net Income (Loss) Available to Common Stockholders, Basic Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Collaborative Arrangement Collaborative Arrangement [Member] Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset Change in unrecognized (loss) gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Change in unrecognized gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Disposal Group, Including Discontinued Operation, Consideration Disposal Group, Including Discontinued Operation, Consideration Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Creon ® Creon ® [Member] Creon ® All Executive Categories All Executive Categories [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Famy Life Sciences Famy Life Sciences [Member] Famy Life Sciences Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Share-Based Payment Arrangement, Expense, Tax Benefit Share-Based Payment Arrangement, Expense, Tax Benefit Earnings per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Current Portion of Long-Term Debt Current Portion of Long-Term Debt [Member] Common Stock, Value, Issued Common Stock, Value, Issued Payments to Acquire in Process Research and Development Other Research and Development Expense Plant Divestiture Expenses Plant Divestiture Expenses [Member] Plant Divestiture Expenses Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Legal Matters and Contingencies Legal Matters and Contingencies [Text Block] 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment Senior Notes Senior Notes [Member] Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Disposal Group, Including Discontinued Operation, Transition Services Agreement, Markup Value Disposal Group, Including Discontinued Operation, Transition Services Agreement, Markup Value Disposal Group, Including Discontinued Operation, Transition Services Agreement, Reimbursement Plus Markup Value Litigation Case Type [Domain] Litigation Case [Domain] Other (income) expense, net Other Nonoperating Income (Expense) Other Nonoperating Income (Expense) Entity Filler Category Entity Filer Category Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Disposal Group, Held-for-Sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Share repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Developed Markets (1) Developed Markets Segment [Member] Developed Markets Segment Accounts payable Accounts payable Accounts Payable, Trade, Current Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Celebrex ® Celebrex ® [Member] Celebrex ® 2028 Senior Notes [Member] 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Short-term Debt [Abstract] Short-Term Debt [Abstract] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Other Other Accrued Liabilities, Current Corporate / Other Corporate, Non-Segment [Member] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Litigation Settlement, Amount Awarded to Other Party Litigation Settlement, Amount Awarded to Other Party Proceeds from sale and collection of receivables Proceeds from Sale and Collection of Receivables Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Stated percentage rate Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Goodwill Impairment, Decrease In Fair Value During Period, Percentage Goodwill Impairment, Decrease In Fair Value During Period, Percentage Goodwill Impairment, Decrease In Fair Value During Period, Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Deferred income tax benefit Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Reporting Unit [Axis] Reporting Unit [Axis] Other Defined Benefit Plan, Other Cost (Credit) Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Restructuring Restructuring and Related Activities Disclosure [Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Net Investment Hedging Net Investment Hedging [Member] Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Disposal Group Classification [Domain] Disposal Group Classification [Domain] YEN Term Loan YEN Term Loan [Member] YEN Term Loan Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Dividends payable (in dollars per share) Dividends Payable, Amount Per Share Finite-lived intangible assets, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Chargebacks Chargebacks Chargebacks Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Share-Based Payment Arrangement, Noncash Expense Foreign Tax Authority Foreign Tax Authority [Member] City Area Code City Area Code Earnings (Loss) per Ordinary Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Restructuring and Related Cost, Expected Number of Positions Eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Document Fiscal Year Focus Document Fiscal Year Focus Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Program Name [Domain] Program Name [Domain] [Domain] for Program Name EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Stock Awards Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Cash dividends declared, $0.24 per common share Dividends, Common Stock, Cash Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Financial and Nonfinancial Liabilities, Fair Value Disclosure Liabilities, Fair Value Disclosure Other Revenues Product and Service, Other [Member] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other long-term assets Other long-term assets Other long-term assets Product Rights And Licenses Product Rights And Licenses [Member] Product Rights And Licenses Intellectual Property Developed Technology Rights [Member] Total liabilities and equity Liabilities and Equity Australian Taxation Office Australian Taxation Office [Member] Other assets Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Ownership [Domain] Ownership [Domain] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Net unrealized loss on marketable securities, net of tax Net unrealized gain (loss) on marketable securities, net of tax, beginning of period Net unrealized gain (loss) on marketable securities, net of tax, end of period AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax Xanax ® Xanax ® [Member] Xanax ® Arrangement Duration Trading Arrangement Duration In Process Research and Development In Process Research and Development [Member] Other Assets Schedule of Other Assets, Noncurrent [Table Text Block] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Non-contingent payments for product rights Payments To Acquire Intangible Assets, Financing Activity Payments To Acquire Intangible Assets, Financing Activity Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value Average remaining contractual term for stock awards vested and expected to vest, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Charges Restructuring Charges Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Fair Value of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Business Combinations [Abstract] Business Combinations [Abstract] Termination Date Trading Arrangement Termination Date Foreign currency translation adjustment Foreign currency translation adjustment, beginning of period Foreign currency translation adjustment, end of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Ordinary shares, shares authorized Common Stock, Shares Authorized 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Available-for-sale fixed income securities Debt Securities, Available-for-Sale Number Of Scottish Health Boards, NHS Scotland Number Of Scottish Health Boards, NHS Scotland Number Of Scottish Health Boards, NHS Scotland Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Short-term borrowings Short-Term Debt Equity Securities, FV-NI, Gain (Loss) Equity Securities, FV-NI, Gain (Loss) Convertible Preferred Stock Convertible Preferred Stock [Member] Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Measurement Input Type [Axis] Measurement Input Type [Axis] Derivative [Line Items] Derivative [Line Items] Award Timing Disclosures [Line Items] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Gain (Loss) on Investments Gain (Loss) on Investments Additional paid-in capital Additional Paid in Capital Amitiza ® Amitiza ® [Member] Amitiza ® Restructuring Plan [Axis] Restructuring Plan [Axis] Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Current portion of long-term debt Debt, Current Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Insider Trading Arrangements [Line Items] Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Employee Related Costs Employee Severance [Member] Change in short-term borrowings, net Proceeds from (Repayments of) Short-Term Debt Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Disposal Group Name [Axis] Disposal Group Name [Axis] Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Corporate and Other Corporate and Other [Member] Payments of long-term debt Repayments of Long-Term Debt Lipitor Lipitor ® [Member] Lipitor ® Entity Central Index Key Entity Central Index Key Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Finished goods Inventory, Finished Goods, Net of Reserves Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Restructuring and Related Cost, Expected Number of Facilities to be Eliminated Income Tax Authority [Domain] Income Tax Authority [Domain] Payroll and employee benefit liabilities Employee-related Liabilities, Current Payments of financing fees Payments of Financing Costs Other [Member] Other Litigation Other [Member] Other Exit Costs Other Restructuring [Member] Name Trading Arrangement, Individual Name Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Brands Brands [Member] Brands Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Other comprehensive earnings (loss), reclassification adjustment from AOCE, pension and other postretirement benefit plans, for net gain (loss), before tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Net sales Sales Revenue, Goods, Net Revenue from Contract with Customer, Excluding Assessed Tax Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Licensing Agreements Licensing Agreements [Member] Business Combination Contingent Consideration Liability Payments Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining Long-term debt Long-Term Debt, Excluding Current Maturities Diluted Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Operating expenses: Operating Expenses [Abstract] Product Liability Product Liability [Member] Product Liability Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Issuance of restricted stock, net of shares withheld (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Europe Segment Europe Segment [Member] Europe Segment Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Effexor ® Effexor ® [Member] Effexor ® Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2027 Long-Term Debt, Maturity, Year Five Reconciling items: Segment Reconciling Items [Member] Norvasc Norvasc ® [Member] Norvasc ® Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Weighted average grant-date fair value per share, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Construction in progress Construction in Progress [Member] Other Comprehensive Income (Loss), before Tax, Total Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Viatris Inc. Viatris Inc. [Member] Viatris Inc. Non-PEO NEO Non-PEO NEO [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Equity Securities, FV-NI, Cost Equity Securities, FV-NI, Cost Debt Instrument [Line Items] Debt Instrument [Line Items] Scenario [Axis] Scenario [Axis] Basic Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Basic Unamortized debt issuance expense Unamortized Debt Issuance Expense Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] 2016 Revolving Credit Facility 2016 Senior Revolving Credit Facility [Member] 2016 Senior Revolving Credit Facility [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Ministry of Finance, India Ministry of Finance, India [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Mapi Pharma Ltd. Mapi Pharma Ltd. [Member] Mapi Pharma Ltd. Summary of Long-Term Debt Schedule of Debt [Table Text Block] Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] 2048 Senior Notes [Member] 2048 Senior Notes [Member] 2048 Senior Notes [Member]